Pub. Date : 2021 May
PMID : 33585999
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer. | ruxolitinib | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 2 | We aimed to identify the recommended phase 2 dose (RP2D) of ruxolitinib in combination with paclitaxel in patients with HER2-negative metastatic breast cancer (MBC). | ruxolitinib | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |